fbpx Skip to main content
 

Search

Janssen Search

Search results

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 68 OF 77

Pages

Article Type:  Disease Interception Accelerator Partner with the Janssen Prevention Center The Janssen Prevention Center (JPC) is a research group within Janssen. Launched at the start of 2015, the center will explore new approaches to disease prevention ...

Stopping Type 1 Diabetes Before It Starts Each year, World Diabetes Day is celebrated on November 14, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922. For nearly a century, insulin has been helping people ...

About the World Without Disease Accelerator Our Mission Consistent with Johnson & Johnson’s transformational medical innovation strategy, the mission of the World Without Disease Accelerator (WWDA) is to discover, develop and prepare for the ...

Janssen is a sponsor of the World Neuroscience Innovation Forum on March 27, 2017, in London. The conference will cover the latest in neuroscience research and innovation. The goal of the London Forum is to spark new insights, therapeutic paths and ...

Clinical Trials What is a Clinical Trial? One method for gaining access to investigational medicines is to enroll in a clinical trial. Clinical trials are scientific studies in which investigational medicines are tested to make sure they are safe and ...

The Art of Getting Lost Janssen proudly features artwork created by people affected by the illnesses and diseases that we are dedicated to helping prevent and treat. Please visit our art gallery to learn more about the artists and view more artwork. Jane ...

Pioneering Preventive Medicine There is a huge need to prevent illnesses associated with aging. Over the past 100 years, preventive strategies have been very successful in controlling infectious diseases. We believe this success can be broadened to keep ...

Healthy Baby Initiative While childhood disease is often diagnosed a few years after the birth of a child, recent science indicates that some disease root causes may initiate early in life. 1 Pregnancy and early childhood years provide a unique window for ...

Article Type:  Human Microbiome Institute Vast Potential Applications The human genome marked a revolutionary shift in research by providing the scientific community with access to more than 20,000 targets with the potential to impact disease. Today, the ...

Calvin Schmidt is Global Commercial Strategy Leader (GCSL) for the Cardiovascular & Metabolism (CVM) therapeutic area and the GCSL for the newly created Johnson & Johnson Innovation World Without Disease Accelerator (WWDA). CVM is maximizing the ...

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 68 OF 77

Pages